Patents by Inventor Kevin Coleman

Kevin Coleman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11922733
    Abstract: A method of enrolling a user at a biometric lockset is described. The method includes receiving user access information from a mobile device of an administrative user of the biometric lockset. The user access information indicates to the biometric lockset to enter an enrollment mode in which a user identity is associated with fingerprint data in a user entry within a memory of the biometric lockset. A plurality of different light codes are displayed on the lockset, each one of the plurality of light codes representative of a different state of fingerprint data capture. A message is transmitted to the mobile device, and corresponds to the light code displayed at the lockset. The completed fingerprint data is stored in association with the user identity of the user in the user entry.
    Type: Grant
    Filed: November 11, 2022
    Date of Patent: March 5, 2024
    Assignee: ASSA ABLOY Americas Residential Inc.
    Inventors: Wei Hsu, Kevin Pasma, Zachary Keoki Hong, Jason Tu, Donnie Viajar, Ali Atash, Kevin Coleman
  • Publication number: 20230144744
    Abstract: A method of enrolling a user at a biometric lockset is described. The method includes receiving user access information from a mobile device of an administrative user of the biometric lockset. The user access information indicates to the biometric lockset to enter an enrollment mode in which a user identity is associated with fingerprint data in a user entry within a memory of the biometric lockset. A plurality of different light codes are displayed on the lockset, each one of the plurality of light codes representative of a different state of fingerprint data capture. A message is transmitted to the mobile device, and corresponds to the light code displayed at the lockset. The completed fingerprint data is stored in association with the user identity of the user in the user entry.
    Type: Application
    Filed: November 11, 2022
    Publication date: May 11, 2023
    Inventors: Wei Hsu, Kevin Pasma, Zachary Keoki Hong, Jason Tu, Donnie Viajar, Ali Atash, Kevin Coleman
  • Patent number: 11501579
    Abstract: A method of enrolling a user at a biometric lockset is described. The method includes receiving user access information from a mobile device of an administrative user of the biometric lockset. The user access information indicates to the biometric lockset to enter an enrollment mode in which a user identity is associated with fingerprint data in a user entry within a memory of the biometric lockset. A plurality of different light codes are displayed on the lockset, each one of the plurality of light codes representative of a different state of fingerprint data capture. A message is transmitted to the mobile device, and corresponds to the light code displayed at the lockset. The completed fingerprint data is stored in association with the user identity of the user in the user entry.
    Type: Grant
    Filed: November 25, 2020
    Date of Patent: November 15, 2022
    Assignee: Spectrum Brands, Inc.
    Inventors: Wei Hsu, Kevin Pasma, Zachary Keoki Hong, Jason Tu, Donnie Viajar, Ali Atash, Kevin Coleman
  • Publication number: 20210158067
    Abstract: A method of enrolling a user at a biometric lockset is described. The method includes receiving user access information from a mobile device of an administrative user of the biometric lockset. The user access information indicates to the biometric lockset to enter an enrollment mode in which a user identity is associated with fingerprint data in a user entry within a memory of the biometric lockset. A plurality of different light codes are displayed on the lockset, each one of the plurality of light codes representative of a different state of fingerprint data capture. A message is transmitted to the mobile device, and corresponds to the light code displayed at the lockset. The completed fingerprint data is stored in association with the user identity of the user in the user entry.
    Type: Application
    Filed: November 25, 2020
    Publication date: May 27, 2021
    Inventors: Wei Hsu, Kevin Pasma, Zachary Keoki Hong, Jason Tu, Donnie Viajar, Ali Atash, Kevin Coleman
  • Patent number: 8562985
    Abstract: The present invention relates to antibodies including human antibodies and antigen-binding portions thereof that specifically bind to c-Met, preferably human c-Met, and that function to inhibit c-Met. The invention also relates to human anti-c-Met antibodies and antigen-binding portions thereof. The invention also relates to antibodies that are chimeric, bispecific, derivatized, single chain antibodies or portions of fusion proteins. The invention also relates to isolated heavy and light chain immunoglobulins derived from human anti-c-Met antibodies and nucleic acid molecules encoding such immunoglobulins. The present invention also relates to methods of making human anti-c-Met antibodies, compositions comprising these antibodies and methods of using the antibodies and compositions for diagnosis and treatment. The invention also provides gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules that comprise the human anti-c-Met antibodies.
    Type: Grant
    Filed: April 24, 2012
    Date of Patent: October 22, 2013
    Assignees: Amgen Fremont Inc., Pfizer Inc.
    Inventors: Neil R. Michaud, Shama Kajiji, Gary Borzillo, Vahe Bedian, Kevin Coleman, Larry L. Green, Xiao-Chi Jia
  • Publication number: 20120321614
    Abstract: The present invention relates to antibodies including human antibodies and antigen-binding portions thereof that specifically bind to c-Met, preferably human c-Met, and that function to inhibit c-Met. The invention also relates to human anti-c-Met antibodies and antigen-binding portions thereof. The invention also relates to antibodies that are chimeric, bispecific, derivatized, single chain antibodies or portions of fusion proteins. The invention also relates to isolated heavy and light chain immunoglobulins derived from human anti-c-Met antibodies and nucleic acid molecules encoding such immunoglobulins. The present invention also relates to methods of making human anti-c-Met antibodies, compositions comprising these antibodies and methods of using the antibodies and compositions for diagnosis and treatment. The invention also provides gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules that comprise the human anti-c-Met antibodies.
    Type: Application
    Filed: April 24, 2012
    Publication date: December 20, 2012
    Applicants: Pfizer, Inc., Amgen Fremont Inc.
    Inventors: Neil R. Michaud, Shama Kajiji, Gary Borzillo, Vahe Bedian, Kevin Coleman, Larry L. Green, Xiao-Chi Jia
  • Patent number: 8163280
    Abstract: The present invention relates to antibodies including human antibodies and antigen-binding portions thereof that specifically bind to c-Met, preferably human c-Met, and that function to inhibit c-Met. The invention also relates to human anti-c-Met antibodies and antigen-binding portions thereof. The invention also relates to antibodies that are chimeric, bispecific, derivatized, single chain antibodies or portions of fusion proteins. The invention also relates to isolated heavy and light chain immunoglobulins derived from human anti-c-Met antibodies and nucleic acid molecules encoding such immunoglobulins. The present invention also relates to methods of making human anti-c-Met antibodies, compositions comprising these antibodies and methods of using the antibodies and compositions for diagnosis and treatment. The invention also provides gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules that comprise the human anti-c-Met antibodies.
    Type: Grant
    Filed: January 26, 2009
    Date of Patent: April 24, 2012
    Assignees: Amgen Fremont Inc., Pfizer Inc.
    Inventors: Neil R. Michaud, Shama Kajiji, Gary Borzillo, Vahe Bedian, Kevin Coleman, Larry L. Green, Xiao-Chi Jia
  • Publication number: 20100040629
    Abstract: The present invention relates to antibodies including human antibodies and antigen-binding portions thereof that specifically bind to c-Met, preferably human c-Met, and that function to inhibit c-Met. The invention also relates to human anti-c-Met antibodies and antigen-binding portions thereof. The invention also relates to antibodies that are chimeric, bispecific, derivatized, single chain antibodies or portions of fusion proteins. The invention also relates to isolated heavy and light chain immunoglobulins derived from human anti-c-Met antibodies and nucleic acid molecules encoding such immunoglobulins. The present invention also relates to methods of making human anti-c-Met antibodies, compositions comprising these antibodies and methods of using the antibodies and compositions for diagnosis and treatment. The invention also provides gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules that comprise the human anti-c-Met antibodies.
    Type: Application
    Filed: January 26, 2009
    Publication date: February 18, 2010
    Applicants: Abgenix, Inc., Pfizer, Inc.
    Inventors: Neil R. Michaud, Shama Kajiji, Gary Borzillo, Vahe Bedian, Kevin Coleman, Larry L. Green, Xiao-Chi Jia
  • Patent number: 7498420
    Abstract: The present invention relates to antibodies including human antibodies and antigen-binding portions thereof that specifically bind to c-Met, preferably human c-Met, and that function to inhibit c-Met. The invention also relates to human anti-c-Met antibodies and antigen-binding portions thereof. The invention also relates to antibodies that are chimeric, bispecific, derivatized, single chain antibodies or portions of fusion proteins. The invention also relates to isolated heavy and light chain immunoglobulins derived from human anti-c-Met antibodies and nucleic acid molecules encoding such immunoglobulins. The present invention also relates to methods of making human anti-c-Met antibodies, compositions comprising these antibodies and methods of using the antibodies and compositions for diagnosis and treatment. The invention also provides gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules that comprise the human anti-c-Met antibodies.
    Type: Grant
    Filed: August 3, 2004
    Date of Patent: March 3, 2009
    Assignees: Amgen Fremont Inc., Pfizer Inc,
    Inventors: Neil R. Michaud, Shama Kajiji, Gary Borzillo, Vahe Bedian, Kevin Coleman, Larry L. Green, Xiao-Chi Jia
  • Publication number: 20050054019
    Abstract: The present invention relates to antibodies including human antibodies and antigen-binding portions thereof that specifically bind to c-Met, preferably human c-Met, and that function to inhibit c-Met. The invention also relates to human anti-c-Met antibodies and antigen-binding portions thereof. The invention also relates to antibodies that are chimeric, bispecific, derivatized, single chain antibodies or portions of fusion proteins. The invention also relates to isolated heavy and light chain immunoglobulins derived from human anti-c-Met antibodies and nucleic acid molecules encoding such immunoglobulins. The present invention also relates to methods of making human anti-c-Met antibodies, compositions comprising these antibodies and methods of using the antibodies and compositions for diagnosis and treatment. The invention also provides gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules that comprise the human anti-c-Met antibodies.
    Type: Application
    Filed: August 3, 2004
    Publication date: March 10, 2005
    Inventors: Neil Michaud, Shama Kajiji, Gary Borzillo, Vahe Bedian, Kevin Coleman, Larry Green, Xiao-Chi Jia
  • Patent number: 5620099
    Abstract: The invention relates to a combined portable scoring system and storage/carrier unit. There is disclosed a portable storage/carrier unit which is intended to be used for storing and carrying sporting equipment of any type when used or not used for scoring a game. Upon arrival at a game site, the equipment and first-aid supplies are removed as needed from the storage/carrier unit, closed and placed in an upright position. The storage/carrier unit includes a plurality of pockets formed in the outer planar surface of at least one side of the unit by a plurality of continuous tracks and accommodates scoring number packets, home team and guest team names as well as a sponsor's name. A centrally located rotary pointer dial is provided to indicate the inning or quarter of play. An out indicator is provided as well.
    Type: Grant
    Filed: November 28, 1994
    Date of Patent: April 15, 1997
    Inventors: Earl H. Bickett, Kevin Coleman, Michael Yurkovic